Synthesis of a radiobrominated analog of SCH 23390, a selfctive dopamine D1/DA1 antagonist
β Scribed by Onofre T. De Jesus; Glenn J. Van Hoffaert; Dana Glock; Leon I. Goldber; Arnold H. Friedman
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- French
- Weight
- 289 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
A r a d i o b r o d n a t e d analog of SCH 23390, a s e l e c t i v e dopamine D1/DAI a n t a g o n i s t was prepared. were obtained w i t h i n 15 minutes r e a c t i o n a t r o m temperature. The s y n t h e s i s was v a l i d a t e d by performing both p h y s i c a l (MR and mass spectroscopy) and b i o l o g i c a l tests on t h e product. s t u d i e s suggest t h a t 75Br-labelled SCH 23390 analog would be a u s e f u l ligand f o r t h e s t u d i e s of CNS dopamine D1 r e c e p t o r s by p o s i t r o n emission tomography. R a d i o c h c d c a l y i e l d s of up t o 60%
π SIMILAR VOLUMES
The optimal conditions for the synthesis of 11C-labelled SCH 23390 by radio-methylation of its desmethyl precursor, SCH 24518, with [11C]iodomethane are described. Isocratic reversed phase HPLC was used for the purification of [11C]SCH 23390. The specific activity range in 30 runs was 10-235 Ci/mmol
A new synthesis is described for the production of the positron emitting radiopharmaceutical R-(+)-7-chloro-8-hydroxy-2,3,4,5-tetrahydro-3-N-[11C]methyl-1-phenyl-1H- 3-benzazepine (SCH 23390, 2a). This novel method involves reductive carboxylation, in which [11C]CO2 is reacted with the trimethylsily
Dopamine D 1 -receptor binding in the basal ganglia is differentially regulated by subtype nonspecific dopamine antagonists such as the antipsychotic, Fluphenazine. The purpose of the present study was to determine the relative contributions of D 1 and D 2 receptor systems in the regulation of basal
This study examined the effects of both systemic and intraaccumbens administration of SCH-23390 in rats on dopamine D1 receptor occupancy and on locomotor activity produced by intraaccumbens infusion of cocaine. In experiment 1, rats received SCH-23390 (0-1 mg/kg, IP) 15 minutes prior to intraaccumb